Researchers to Develop Predictive Model for Opioid Addiction in High-Risk Patients
June 13, 2024
UC San Diego School of Medicine part of $50M initiative to use predictive AI to help fight opioid abuse.
June 13, 2024
UC San Diego School of Medicine part of $50M initiative to use predictive AI to help fight opioid abuse.
January 24, 2020
Approximately one-quarter of patients who are prescribed opioids for chronic pain misuse them, with five to 10 percent developing an opioid use disorder or addiction. In a new study, UC San Diego researchers found that opioid dependence produced permanent changes in the brains of rats.
August 28, 2019
As the opioid tramadol has grown in popularity so too have documented cases of adverse effects. In a new study, researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego show that patients who take tramadol are at greater risk for hypoglycemia, abnormally low blood sugar.
February 20, 2019
UC San Diego Health is among 31 health facilities selected from across the state to participate in the California Bridge Program, an accelerated, 18-month training program for health care providers to enhance access to around-the-clock treatment for patients with opioid use disorder.
March 25, 2021
UC San Diego School of Medicine researchers report that opioid users who participated in a 12-step abstinence program and recently stopped using drugs refused to take home naloxone, even if having it on hand might save lives.
May 20, 2021
Researchers at University of California San Diego School of Medicine found that functional impairments among adults aged 50 and older are associated with a higher risk of medical cannabis use; and prescription opioid and tranquilizer/sedative use and misuse.
April 27, 2020
Antibiotic treatment — which depletes gut microbes — drastically changes the parts of a rat’s brain that are activated during opioid addiction and withdrawal.
October 5, 2023
Researchers at University of California San Diego School of Medicine have used single-cell sequencing to identify a potential new treatment for cocaine addiction and shed new light on the molecular underpinnings of addiction.
August 10, 2017
QI Innovation Space member CARI Therapeutics has received a grant from the National Institutes of Health to collaboratively develop a biosensor that will detect the presence of opioids in patients in recovery.
April 27, 2022
CARI Health, a startup in the Institute for the Global Entrepreneur’s MedTech Accelerator, was named a Connect “Cool Company” on the heels of winning the $300,000 grand prize at the San Diego Angel Conference.